Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cervical cancer screening

04.11.2003


No proven benefit of detection of human papillomavirus alone compared with the conventional Pap smear

Under the aegis of the French Society of Clinical Cytology, physicians at the Institut Curie have evaluated the relevance of the papillomavirus detection test, Hybrid Capture‚ II, in screening for cervical cancer, the second most common cancer in women worldwide. They have shown that this test cannot replace cytological analysis of the cervical smear.
For the first time a learned society, the French Society of Clinical Cytology, has organized a multicenter, national study in general practice. Cervical cancer screening is one of 70 priority measures in France’s Cancer Plan, and an important goal is to establish a test that combines reliability, feasibility and affordability. This work was published in the October 2003 issue of the American Journal of Clinical Pathology.


Cervical cancer is the second most common cancer in women, with 465 000 new cases and 200 000 deaths worldwide every year. In France, 3 387 new cases and 1 000 deaths were recorded in 2000. Cervical cancer affects women in all age ranges, from 25 years upwards.

Cervical cancer screening: a national priority

Early detection of cervical cancer through intensified screening is one of the 70 measures of the Cancer Plan launched in France by the President of the Republic. Screening is based on the cervical smear test. In this simple and painless test, cells are collected from the surface of the cervix and are examined under the microscope for any anomaly suggestive of lesions that are precancerous or cancerous. It should be performed every three years.

The Cancer Plan is intended to broaden availability of the smear test (family planning, occupational medicine...) to women who do not have a gynecologist, so as to intensify information actions and facilitate testing for papillomavirus infection.
In France, generalization of the smear test has already led to a reduction in the incidence of cervical cancer: the number of cases decreased from 5 992 in 1975 to 3 387 in 2000, i.e. a 46 % decrease in 25 years.

This incidence though is still high, possibly due to the fact that the female population is not fully covered and also because some women develop cervical cancer despite regular smear tests, which clearly have shortcomings (false-negatives, absence of abnormal cells in the area of the smear…). Screening should be improved by the implementation of more sensitive tests.

Comparison of detection of HPV and cytologic analysis

Close to 90% of cervical cancers develop from pre-invasive lesions due to a human papillomavirus (HPV). The efficiency of screening could be improved by the inclusion of testing for HPV.

Under the aegis of the French Society of Clinical Cytology, physicians of the Institut Curie, coordinated by Dr Béatrix Cochand-Priollet (1) have evaluated the efficiency and relevance of the Hybrid Capture‚ II papillomavirus DNA test (HC-II) (2). This test performed on the cervical smear detects papillomavirus DNA and distinguishes high-risk from low-risk HPVs.

By comparing cytologic analyses and the HC-II test in 1 785 patients, the Institut Curie physicians have shown that the HC-II test performed alone is less sensitive than cytologic analysis of a cervical smear.

In conclusion, comparative analysis of the sensitivity and specificity of the HC-II technique and of the conventional Pap smear reveals no advantage of HPV detection alone in the framework of cervical cancer screening.

It is therefore unlikely that the HC-II test will replace cytologic analysis, but it could in certain cases be complementary. Further studies are needed to define the role of the HC-II test in cervical cancer screening and follow-up.


Note

(1) Dr Béatrix Cochand-Priollet works in the Pathological Anatomy and Cytology Department of the Hôpital Lariboisière.
(2) This test is manufactured by Digene“ (Gaithersburg, USA).

Catherine Goupillon | Institut Curie

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>